Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met Gene
The results stated that emodin significantly reduced the cell proliferation rate of the MiaPaCa-2 pancreatic cells, and no synergistic effects were observed in this context with hesperetin. However, emodin improved the hesperetin efficacy in pancreatic cells, indicating that structural modification through pharmacokinetics by coupling these two compounds may help to identify novel compounds to treat pancreatic cancer in the future. However, further pancreatic cell lines, such as Panc-1, Bx- PC-3, etc., and in vivo models that include CDX and PDX are needed to verify the combination effect of hespertin and emodin on pancreatic cells.
Authors
- PR Sreelakshmi (ORCID: https://orcid.org/0000-0001-5322-5359)
- Palanisamy Arulselvan
- Muruganantham Bharathi (ORCID: https://orcid.org/0000-0003-3235-5837)
- Sridhar Muthusami (ORCID: https://orcid.org/0000-0002-3595-9081)
- Rangaraj Kaviyaprabha
- Thandaserry Vasudevan Miji
Institutions
- Karpagam Academy of Higher Education (IN)
- Saveetha University (IN)
Publication Details
- Journal
- Protein and Peptide Letters
- Published
- 2025-03-25
- DOI
- https://doi.org/10.2174/0109298665363165250225100109
- Citations
- 4
- Primary Topic
- Medicinal Plants and Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 3.22